Azafaros has successfully raised €132M in funding, indicating strong investor confidence and interest in their innovative approach to rare diseases.
Company Description
Azafaros is a Dutch-based company focused on developing innovative therapies for rare diseases. The company leverages advanced research and technology to create solutions that address unmet medical needs.